Dr Anna Kemp-Casey is a medicines use researcher and Adjunct Research Fellow at The University of Western Australia School of Population Health. Her work focuses on the impact of PBS cost-sharing policies on medication use amongst vulnerable populations. Her research has demonstrated falls in medicines use by low income patients following co-payment increases and safety net changes, and highlighted the financial difficulties faced by patients with chronic illnesses. Dr Kemp-Casey has discussed cost-barriers to PBS medicine use in a number of editorials and opinion pieces in The Weekend Australia, Australian Pharmacist and the Australian Journal of Pharmacy. She also contributed a chapter on methods for analysing medicines policy impacts in the international health text, Translational Research for Primary Healthcare (Nova Science, New York, 2012). Dr Kemp-Casey has received >$4 million in competitive funding for her PBS medicine utilisation research to date. In 2009 she co-founded Medicines Use Research Australia (MURA), a collaboration of researchers and policy makers engaged in pharmaco-epidemiological research and committed to developing future Australian research capacity in this field.